Abbott announced that the US Food and Drug Administration (FDA) has approved its Proclaim XR spinal cord stimulation (SCS) system to treat painful diabetic peripheral neuropathy (DPN), a debilitating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results